Cash from Financing (Quarterly) Chart

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 16.85M
March 31, 2026 5.487M
December 31, 2025 0.002M
September 30, 2025 27.13M
June 30, 2025 16.46M
March 31, 2025 15.44M
December 31, 2024 18.00M
September 30, 2024 0.094M
June 30, 2024 11.63M
March 31, 2024 18.52M
December 31, 2023 5.00M
September 30, 2023 0.275M
June 30, 2023 0.075M
Date Value
March 31, 2023 24.11M
December 31, 2022 0.001M
September 30, 2022 1.922M
June 30, 2022 0.501M
March 31, 2022 0.187M
December 31, 2021 63.74M
September 30, 2021 0.4468M
June 30, 2021 4.586M
March 31, 2021 3.30M
December 31, 2020 1.60M
September 30, 2020 1.076M
June 30, 2020 1.603M
March 31, 2020 1.305M

Cash From Financing Definition

Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

View Cash from Financing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Financing (Quarterly) Benchmarks

View Cash from Financing (Quarterly) Benchmarks
Start Trial
IDEXX Laboratories, Inc. -325.19M
Neogen Corp. -0.30M
QuidelOrtho Corp. 200.60M
Aspira Women's Health, Inc. 1.293M
VolitionRX Ltd. 4.778M